Reviva Pharmaceuticals Holdings, Inc. Shares Issued
Reviva Pharmaceuticals Holdings, Inc. (RVPH) had Shares Issued of 13.11 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-12
- 2026-06-30: Common Stock, Shares, Issued 13.11M shares.
- 2026-03-31: Common Stock, Shares, Issued 12.81M shares.
- 2025-12-31: Common Stock, Shares, Issued 5.87M shares.
- 2025-09-30: Common Stock, Shares, Issued 96.34M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2026-06-30 | 13.11M shares 10-Q · filed 2026-08-12 | |
| 2026-03-31 | 12.81M shares 10-Q · filed 2026-05-13 | |
| 2025-12-31 | 5.87M shares 10-Q · filed 2026-08-12 | |
| 2025-09-30 | 96.34M shares 10-Q · filed 2025-11-13 | |
| 2025-06-30 | 68.00M shares 10-Q · filed 2025-08-14 | |
| 2025-03-31 | 46.74M shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 2.36M shares 10-K · filed 2026-03-30 | 46.58M shares 10-K · filed 2025-04-03 |
| 2024-09-30 | 33.44M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 29.82M shares 10-Q · filed 2024-08-14 | |
| 2024-03-31 | 27.92M shares 10-Q · filed 2024-05-14 | |
| 2023-12-31 | 27.92M shares 10-K · filed 2025-04-03 | |
| 2023-09-30 | 20.65M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 22.65M shares 10-Q · filed 2023-08-14 | |
| 2023-03-31 | 20.45M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 20.45M shares 10-K · filed 2024-04-15 | |
| 2022-09-30 | 20.44M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 15.13M shares 10-Q · filed 2022-08-15 | |
| 2022-03-31 | 15.13M shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 14.43M shares 10-K · filed 2023-03-30 | |
| 2021-09-30 | 13.39M shares 10-Q · filed 2021-11-15 | |
| 2021-06-30 | 13.39M shares 10-Q · filed 2021-08-16 | |
| 2021-03-31 | 9.23M shares 10-Q · filed 2021-05-17 | |
| 2020-12-31 | 9.23M shares 10-K · filed 2022-03-15 | |
| 2020-11-30 | 2.86M shares 10-Q · filed 2021-01-14 | |
| 2020-08-31 | 2.81M shares 10-Q · filed 2020-10-14 | |
| 2020-05-31 | 2.74M shares 10-Q · filed 2020-07-07 | |
| 2020-02-29 | 2.70M shares 10-Q · filed 2021-01-14 | |
| 2019-11-30 | 2.62M shares 10-Q · filed 2020-01-10 | |
| 2019-08-31 | 2.61M shares 10-Q · filed 2019-10-08 | |
| 2019-05-31 | 2.61M shares 10-Q · filed 2019-07-03 | |
| 2019-02-28 | 2.60M shares 10-K · filed 2020-05-04 | |
| 2018-11-30 | 2.60M shares 10-Q · filed 2019-01-09 | |
| 2018-08-31 | 2.60M shares 10-Q · filed 2018-10-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |